Introduction {#Sec1}
============

Petroleum-based plastics are essential elements of our contemporary society, and will remain so for a foreseeable future. Still, the world is standing at the threshold of an era marked by scarce fossil-based resources (Lambert et al. [@CR17]; Foley et al. [@CR7]), which called for a transition towards the production of bio-based bulk chemicals from renewable feedstock (European Parliament CotEU [@CR6]). Among candidate feedstock for bio-based polymer production, lignocellulosic biomass such as corn stover, wheat straw or sugar cane bagasse, are amongst the most promising ones (Gírio et al. [@CR10]). Another readily available lignocellulosic feedstock is the spent sulfite liquor (SSL), one of the main by-products from the pulp and paper industry (Novy et al. [@CR23]).

However, up to now, the bio-based polymers that are entering the market as replacement for their petroleum-based counterparts are produced from simple sugars, such as glucose, or food crop residuals such as glycerol. Polyhydroxyalkanoates (PHAs) are some of the most promising biodegradable biopolymers for a sustainable future (Philip et al. [@CR24]). Poly-(*R*)-3-hydroxybutyrate (PHB), that is naturally produced by several bacterial species as an energy storage depot, typically under conditions of nitrogen starvation (Suriyamongkol et al. [@CR29]; Madison and Huisman [@CR21]), is one of the most studied PHAs. Numerous hosts have been suggested as PHA producers, such as natural PHB-producing bacterial species or engineered *Escherichia coli.* Nevertheless *E. coli* suffers from regular phage infections in industrial production settings (Lian et al. [@CR20]), while the natural PHB-producing bacterial species are not well adapted to harsh environments, such as growth in SSL. Instead baker's yeast *Saccharomyces cerevisiae,* that is known for its tolerance to acidic and inhibitor-rich conditions, is considered one of the favored species for converting the sugars found in SSL into bulk chemicals of interest -- e.g. PHB (Demeke et al. [@CR5]). SSLs are commonly rich in xylose, a pentose sugar that is not naturally consumed by *S. cerevisiae*. Therefore, efficient xylose-metabolizing *S. cerevisiae* strains have been developed (Hahn-Hägerdal et al. [@CR11]; Kim et al. [@CR13]).

The potential of engineered *S. cerevisiae* as a producer of PHAs from pure hexose sugars has previously been explored by several groups. First, only the polyhydroxyalkanoate synthase gene from the PHB producer *Cupriavidus necator* (formerly known as *Ralstonia eutropha* (Vandamme and Coenye [@CR30])) was overexpressed (Leaf et al. [@CR19]) and PHB was produced by the available cytosolic 3-hydroxybutyryl-CoA, derived from the fatty acid β--oxidation pathway. Several strategies aiming at increasing the available pool of precursors have been tested in *S. cerevisiae* in order to increase the yield of PHB, for example addition of the *C. necator* β-ketothiolase and acetoacetyl-CoA reductase genes (Carlson and Srienc [@CR4]; Breuer et al. [@CR2]), enzymes for boosting ethanol assimilation and acetyl-CoA synthesis (Kocharin et al. [@CR15]) and addition of the phosphoketolase pathway and non-phosphorylating NADP^+^-dependent glyceraldehyde-3-phosphate dehydrogenase for increasing the NADPH pool (Kocharin et al. [@CR16]). Here, we demonstrate that *S. cerevisiae* can also be engineered to produce PHB from [d]{.smallcaps}-xylose.

Materials and methods {#Sec2}
=====================

Strains, media and culture conditions {#Sec3}
-------------------------------------

Plasmids and yeast strains used in this study are listed in Table [1](#Tab1){ref-type="table"}. *E. coli* strain NEB5-α (New England Biolabs) was used for sub-cloning of plasmid DNA and further propagation. Lysogeny broth (LB) (5 g L^−1^ yeast extract, 10 g L^−1^ peptone, 5 g L^−1^ NaCl, pH 7.0) medium was used for routine culturing of *E. coli* and 50 mg L^−1^ ampicillin was added to LB when needed. Bacterial transformants were selected on solid LB plates (15 g L^−1^ agar), supplemented with ampicillin (50 mg L^−1^), for 16 h at 37°C. Cultures of vector-carrying *E. coli* were recovered from 25% glycerol stocks stored at −80°C and grown in liquid LB medium, supplemented with ampicillin, for 14--16 h at 37°C and 180 rpm in an orbital shaker.Table 1**Plasmids and strains used in this studyPlasmidsRelevant genotypeReference**YIplac128*LEU2*(Gietz and Akio [@CR8])YIpOB8*pTDH3*-*XYL1-tADH1*; *pPGK1-XYL2-tPGK1*; *URA3*(Runquist et al. [@CR26])YIpAGS2YIplac128; *pTEF1*-*PhaA*-*tTEF1*; *pGPM1*-*PhaB1*-*pGPM1*; *pTPI1*-*PhaC1*-*tTPI1*; *LEU2*This study**Yeast strainsRelevant genotypeReference**TMB 3043CEN.PK2-1C; *gre3*Δ; *his3*::*pPGK1-XKS1-tPGK1*, *HIS3*; *tal1*::*pPGK1-TAL1*-*tPGK1*; *tkl1*::*pPGK1-TKL1-tPGK1*; *rki1*::*pPGK1-RKI1-tPGK1*; *rpe1*::*pPGK1-RPE1-tPGK1*; *ura3*, *leu2*(Karhumaa et al. [@CR12])TMB 4440TMB 3043; *ura3*::YIpOB8; *leu2*This studyTMB 4443TMB 4440; *leu2*::YIpAGS2This studyTMB 4444TMB 4440; *leu2*::YIplac128This study

Yeast strains were recovered from 20% glycerol stocks stored at −80°C, by streaking on solid YPD plates (10 g L^−1^ yeast extract, 20 g L^−1^ peptone, 20 g L^−1^ glucose, 15 g L^−1^ agar) for two days at 30°C. Yeast cultures were grown in liquid YPD when preparing the strain for transformation for 14--16 h, or less when required, at 30°C and 180 rpm in an orbital shaker.

Engineered yeast strains were selected on solid YNB medium (6.7 g L^−1^ Yeast Nitrogen Base without amino acids (Becton, Dickinson and Company, USA) supplemented with 20 g L^−1^ glucose or xylose and 15 g L^−1^ agar). Leucine was added for complementation at a concentration of 30 mg L^−1^ when required.

All chemicals were purchased from Sigma-Aldrich if not otherwise stated.

PHB pathway expression vector construction {#Sec4}
------------------------------------------

The PHB pathway genes *PhaA*, *PhaB1*, and *PhaC1* from *C. necator* (Poehlein et al. [@CR25]) were codon optimized towards *S. cerevisiae* and synthesized (Eurofins Genomics, Germany). The codon-optimized genes have been deposited with following accession numbers; *PhaA* \[GenBank:KP681582\], *PhaB1* \[GenBank:KP681583\], *PhaC1* \[GenBank:KP681584\]. The three coding regions were inserted in-between the strong constitutive promoter-terminator pairs of the genes *TEF1*, *TPI1*, *GPM1* (Sun et al. [@CR28]), respectively. The promoters and terminators were amplified directly from the genome of *S. cerevisiae* CEN.PK113-7D (Nijkamp et al. [@CR22]), and the PHB pathway genes were amplified by PCR from respective vector. The fragments were amplified with Phusion Hotstart II polymerase (Thermo Scientific, USA) using the following PCR program: initial denaturation at 98°C for 30 s, 30 cycles of denaturation at 98°C for 10 s, annealing at 65°C (−0.5°C∕cycle) for 30 s and elongation at 72°C for 15 s or 1 min, and a final elongation step for 10 min at 72°C. The three purified promoter, coding sequence and terminator fragments were assembled by overlap extension PCR (OE-PCR). Equimolar fragment amount were mixed, and the following overlap-extension program was used; 98°C for 30 s, then 16 cycles at 98°C for 10 s, 68°C (−0.5°C/cycle) for 30 s, 72°C for 1 min and then hold at 12°C for the addition of amplification primers (50 μM each), whereafter the program continued at 98°C for 30 s, then 20 cycles at 98°C for 30 s, 68°C (−0.5°C/cycle) for 30 s, 72°C for 1 min, and then a final elongation at 72°C for 10 min. The primers were designed such that the flanking ends of the generated fragments overlapped with the neighboring regions, enabling the use of In-Fusion cloning (Clontech, Takara-Bio, Japan). Linear vector fragments of YIplac128 (Gietz and Akio [@CR8]) were generated by double-digestion with Fast Digest *Cfr*9I (*Xma*I) and *Ssp*DI (*Kas*I) (Thermo Scientific, USA). The digested vector, and the three promoter-gene-teminator fragments were mixed in equimolar amounts and were assembled by In-Fusion cloning, according to the supplier's instruction. High efficiency competent NEB5-α cells were transformed according to the supplier's instructions. Plasmids were propagated, a diagnostic restriction digestion was performed and the cloned region was fully sequenced. The oligonucleotides used for the PCRs are listed in Table [2](#Tab2){ref-type="table"}.Table 2**Primers used in the present studyNameAmplification targetSequence (5' to 3')**TEF1p_f*S. cerevisiae TEF1* promoterCTAGAGGATCCCCGGGTATAGCTTCAAAATGTTTCTACTEF1p_rCACGTCAGTCATTTTGTAATTAAAACTTAGATTAGPhaA_fCodon optimized *PhaA* ORF from *C. necator*GTTTTAATTACAAAATGACTGACGTGGTGATTGPhaA_rCACGTCAGTCATTTTGTAATTAAAACTTAGATTAGATTGTEF1t_f*S. cerevisiae TEF1* terminatorGTTGAAAGAAAGTAAGGAGATTGATAAGACTTTTCTEF1t_rGATATAGAGCTCAGATAGCGCCGATCAAAGTPI1p_f*S. cerevisiae TPI1* promoterTCTGAGCTCTATATCTAGGAACCCATCAGTPI1p_rCAATCCTTTGCGTCATTTTTAGTTTATGTATGTGTTTTTTGPhaB1_fCodon optimized *PhaB1* ORF from *C. necator*CATACATAAACTAAAAATGACGCAAAGGATTGCGTATGPhaB1_rGATAATATTTTTATATAATTATATTATTAACCCATGTGTAAGCCACTPI1t_f*S. cerevisiae TPI1* terminatorCACATGGGTTAATAATATAATTATATAAAAATATTATCTTCTTTTCTPI1t_rCTAACTAGTTATATAACAGTTGAAATTTGGATAAGGPM1p_f*S. cerevisiae GPM1* promoterTATATAACTAGTTAGTCGTGCAATGTATGACGPM1p_rCTTTACCAGTGGCCATTATTGTAATATGTGTGTTTGTTTGPhaC1_fCodon optimized *PhaC1* ORF from *C. necator*CATATTACAATAATGGCCACTGGTAAAGGPhaC1_rCATTCATTCTTCAGACTTATGCCTTTGCTTTCACATACGPM1t_f*S. cerevisiae GPM1* terminatorGAAAGCAAAGGCATAAGTCTGAAGAATGAATGATTTGGPM1t_rTACCGCATCAGGCGCCATATTCGAACTGCCCATTCAG

Yeast strain engineering {#Sec5}
------------------------

*S. cerevisiae* TMB 3043 (Karhumaa et al. [@CR12]) was transformed with the *Eco*RV-linearized vector YIpOB8 (Runquist et al. [@CR26]), generating the strain TMB 4440. The yeast cells were transformed using the high-efficiency Li-Ac method (Gietz and Schiestl [@CR9]), and plated on YNB-xylose (20 g L^−1^)-plates, supplemented with leucine (30 mg L^−1^). The strain was subsequently transformed with *Eco*9I-linearized YIpAGS2 or YIp128 -- to form the PHB-producing strain TMB 4443 or the corresponding control strain TMB 4444 (Table [1](#Tab1){ref-type="table"}). Transformed strains were validated by amplifying stretches of the integrated cassette by PCR, using extracted genomic DNA as template and primers found in Table [2](#Tab2){ref-type="table"}.

Aerobic cultivations {#Sec6}
--------------------

For the shake flasks experiments, well-aerated baffled shake flasks were used. Pre-cultures were started by transferring an isolated colony into 5.0 mL of defined buffered YNB-xylose (13.4 g L^−1^ Yeast nitrogen base, 50 g L^−1^ xylose, 50 mM potassium hydrogen phthalate, pH 5.5) in 50 mL conical centrifuge tube, shaking at 30°C at 180 rpm overnight. 50 mL buffered YNB-xylose was inoculated with the pre-culture to a starting OD~620~ of 0.05, in a 250 mL baffled shake flask. The cultures were grown at 30°C at 180 rpm for at least 82 hours. Optical density during growth was monitored at 620 nm using an Ultrospec 2100 Pro spectrophotometer (Amersham Biosciences Corp., USA). Samples were extracted for PHB quantification, OD~620~, cell dry weight measurements, and metabolite analysis, and were done in technical duplicates. Maximum specific growth rate was calculated by the analysis of the exponential growth phase, using a linear regression of the natural logarithm derived from the OD~620~.

For the experiments in bioreactors, unbuffered YNB-xylose (13.4 g L^−1^ Yeast nitrogen base, 50 g L^−1^ xylose) was used as media. Well-controlled Multifors 1.2 L vessels (Infors, Switzerland) were sparged with 1.0 vvm air at 30°C and 300 rpm. A culture volume of 300 mL was inoculated with YNB-xylose freshly grown cells to a starting OD~620~ of 0.05. Silicon antifoam RD emulsion (Dow Corning, USA), 3 M KOH and 3 M H~2~SO~4~ were added as needed in order to avoid the excess of foaming and to keep the pH at 5.5, respectively. Two independent biological replicates were performed for each condition.

Analysis of biomass and metabolites {#Sec7}
-----------------------------------

Cell dry weight was measured in triplicate by filtering a known volume (3.0 to 5.0 mL) of the culture through a pre-weighed nitrocellulose filter with 0.45 μm pore size (PALL, USA). The filters were washed, dried and weighed after equilibrating to room temperature in a desiccator. Biomass was correlated to OD~620~ by a single point calibration, based on the final measuring time point. Concentrations of glucose, xylose, xylitol, glycerol, acetate and ethanol were analyzed by HPLC (Waters, USA). Metabolites were separated using an Aminex HPX-87H ion exchange column (Bio-Rad, USA) at 45°C with 5 mM H~2~SO~4~ as mobile phase, at a flow rate of 0.6 mL min^−1^. All compounds were detected with a RID-10A refractive index detector (Shimadzu, Japan). Concentrations of metabolites were calculated from an external seven-point standard calibration curve. Samples were analyzed in technical duplicates.

PHB quantification {#Sec8}
------------------

The method used relied on the quantitative conversion of PHB to crotonic acid catalyzed by hot concentrated sulfuric acid (Law and Slepecky [@CR18]). A culture volume of 0.5 or 1.0 mL was harvested and transferred to a 1.5 mL microcentrifuge tube. The harvested cells were centrifuged for 5 min at 6000 × *g* and the supernatant was discarded by careful aspiration (FTA-1, Biosan, Latvia). The pellet was washed with 1.0 mL ultrapure H~2~O and resuspended by vortexing, centrifuged for 5 min at 6000 × *g* and the supernatant was discarded. This wash step was repeated two times. H~2~SO~4~ (0.5 mL, 96% v/v) was added to the pellet. The pellet was resuspended by careful pipetting, and the open-lid tubes were transferred to a heat block (Grant QBD1, Grant Instruments, UK), and incubated at 95°C for 1 h. The resulting solution was diluted 20 times by a serial dilution and further analyzed by HPLC, using the same conditions as for the analysis of metabolites, and quantified by comparing to an external calibration curve of crotonic acid. Commercially available PHB (\#363502, Sigma-Aldrich) was used as method control and was processed similarly as pelletized cells. Samples were analyzed in technical duplicates.

Results {#Sec9}
=======

Construction of the expression vector carrying the PHB pathway genes {#Sec10}
--------------------------------------------------------------------

The *C. necator* PHB pathway, consisting of a β-ketothiolase (acetyl-CoA acetyltransferase) (encoded by *PhaA*), an acetoacetyl-CoA reductase (encoded by *PhaB1*), and a PHB synthase (encoded by *PhaC1*) (Figure [1](#Fig1){ref-type="fig"}A), was chosen for PHB production in *S. cerevisiae* as it has been successfully used in the past (see e.g. (Carlson and Srienc [@CR4]; Kocharin et al. [@CR15]; Breuer et al. [@CR2])). The genes, ordered from MWG Eurofins, were codon optimized for *S. cerevisiae*, which notably led to lower GC-content (47--52% GC) than the native bacterial genes (63--68% GC). All three genes were cloned behind a strong constitutive promoter (*pTEF1*, *pTPI1* and *pGPM1* for *PhaA*, *PhaB1* and *PhaC1*, respectively) into a single large vector, named YIpAGS2 (Figure [1](#Fig1){ref-type="fig"}B), based on YIplac128 which has a *LEU2* gene for complementation of auxotrophic strains. The entire pathway was sequenced and validated.Figure 1**The PHB metabolic pathway, consisting of A) metabolite structures, involved enzymes, cofactors and B) the genes and regulatory sequences in the integrative vector YIpAGS2 in a schematic representation.**

Strain engineering {#Sec11}
------------------

*S. cerevisiae* strain TMB 3043 (Karhumaa et al. [@CR12]), that has been engineered for increased flux from xylulose to glycolysis, through the overexpression of xylulokinase and the non-oxidative pentose phosphate pathway genes, was transformed with YIpOB8 carrying the *Scheffersomyces stipitis* xylose genes encoding xylose reductase (XR) and xylitol dehydrogenase (XDH) (Bengtsson et al. [@CR1]), generating strain TMB 4440.

TMB 4440 was further transformed with the constructed linearized YIpAGS2 that carries *C. necator* PHB pathway gene or with a linearized integrative control vector (YIplac128), generating strains TMB 4443 (PHB+) and TMB 4444 (PHB-), respectively.

Evaluation of PHB production from xylose {#Sec12}
----------------------------------------

The generated strains were compared aerobically in well-stirred baffled flasks to evaluate their PHB production capacity. The strains were grown with [d]{.smallcaps}-xylose as sole carbon source, until the cultures reached late stationary phase. Metabolites were analyzed and cell dry weight calculated. Representative growth plots for the control strain TMB 4444 and the TMB 4443 strain expressing the PHB pathway genes are displayed in Figure [2](#Fig2){ref-type="fig"}A and [2](#Fig2){ref-type="fig"}B, respectively.Figure 2**Representative aerobic growth and metabolite profiles from recombinant** ***S. cerevisiae*** **strains A) TMB 4444 (Control strain, PHB-) and B) TMB 4443 (PHB+), with xylose defined medium in buffered shake flask cultures.** *Legend*: xylose(■); biomass(●); glycerol(♦); ethanol(▲); PHB(□); xylitol(○); acetate(◊).

As expected, both strains were able to grow on xylose. Xylitol, acetate and ethanol were the main by-products (Table [3](#Tab3){ref-type="table"}). However strain TMB 4443 (PHB+) generated less biomass and xylitol and more ethanol than the control strain TMB 4444. This was accompanied by PHB production that appeared to be concomitant with biomass formation. In the early exponential phase, PHB content rose more rapidly than the biomass titers under these shake flask conditions (Figure [2](#Fig2){ref-type="fig"}B). PHB yield peaked at 1.17 ± 0.33 mg PHB g^−1^ xylose consumed (Table [3](#Tab3){ref-type="table"}) at the end of the exponential phase and further ethanol consumption did not result in additional PHB accumulation (Figure [2](#Fig2){ref-type="fig"}B).Table 3**Physiological results of the strains grown aerobically on xylose on shake flasks or bioreactorsStrainGrowth conditionGrowth rate** ***μ*** ~**max**~ **(h** ^**−1**^ **)YieldsPHB titer (mg/L)Final PHB content (% CDW)Xylose/sugars consumed (%)Y** ~**sx**~ **(g/g Xyl)Y** ~**sEtOH**~ **(g/g Xyl)Y** ~**sAc**~ **(g/g Xyl)Y** ~**sXylitol**~ **(g/g Xyl)Y** ~**sGly**~ **(g/g Xyl)Y** ~**sPHB**~ **(mg/g Xyl)**TMB 4443Shake flask0.231 ± 0.010.11 ± 0.020.10 ± 0.050.14 ± 0.00.05 ± 0.030.01 ± 0.01.17 ± 0.1845.0 ± 3.541.04 ± 0.0376.8 ± 4.6TMB 4444Shake flask0.249 ± 0.010.14 ± 0.00.06 ± 0.00.14 ± 0.00.10 ± 0.00.02 ± 0.00.0 ± 0.00.0 ± 0.00.0 ± 0.080.1 ± 3.0TMB 4443Bioreactor0.184 ± 0.010.41 ± 0.020.004 ± 0.00.0 ± 0.00.028 ± 0.00.0 ± 0.01.99 ± 0.15101.7 ± 7.10.49 ± 0.06100 ± 0The values reported are calculated for aerobic cultivations on defined media with xylose (50 g L^−1^) as carbon source. The specific growth rate is calculated for the exponential phase. Yields and titers are calculated from a single time point in the early stationary phase. Reported values represent the mean ± SD of at least two independent cultivations performed. Y~sx~: biomass yield on xylose, Y~sEtOH~: yield of ethanol on xylose, Y~sAc~: yield of acetate on xylose, Y~sXylitol~: yield of xylitol on xylose, Y~sGly~: yield of glycerol on xylose, Y~sPHB~: yield of PHB on xylose. PHB titer: The volumetric PHB titer. PHB/CDW: The PHB component as percentage of total cell dry weight.

As acetate levels were high and xylose utilization stopped before depletion, PHB production was also evaluated in another set-up using well-aerated and pH-controlled bioreactor for strain TMB 4443 (PHB+). Under these conditions, full xylose consumption was observed within 48 hours (Figure [3](#Fig3){ref-type="fig"}) and biomass accumulation was very high in comparison to the shake flask-experiments. Also, acetate, ethanol and xylitol production was significantly reduced. At the end of the exponential phase (48 hours), maximum biomass accumulation was reached and cellular PHB reached 0.49 ± 0.06% PHB/CDW, corresponding to a PHB yield of 1.99 ± 0.15 mg PHB g^−1^ xylose (Figure [3](#Fig3){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}).Figure 3**Representative fully aerobic batch growth and metabolite profile from recombinant** ***S. cerevisiae*** **strain TMB 4443 (PHB+) in xylose defined medium at pH 5.5 using a well-controlled bioreactor.** *Legend*: xylose(■); biomass(●); glycerol(♦); ethanol(▲); PHB(□); xylitol(○); acetate(◊).

Discussion {#Sec13}
==========

In the present study, PHB production from xylose was demonstrated using recombinant *Saccharomyces cerevisiae.* PHB production occurred under exponential growth phase, concomitant with the accumulation of ethanol and other by-products. The maximal PHB yield from xylose (1.99 ± 0.15 mg PHB g^−1^ xylose, or 2.79 Cmmol PHB Cmol^−1^ xylose), that was achieved in well-aerated bioreactors, was comparable to reported non-xylose engineered strains harboring equivalent *C. necator* PHB pathways growing on glucose (Table [4](#Tab4){ref-type="table"}), thereby demonstrating the potential of using a pentose carbon source, and more generally C5-rich lignocellulosic substrates for PHB production. One of the possible reasons might be that xylose conversion to pyruvate does not involve the oxidative pentose phosphate pathway that is the main source of NADPH inside the cell (Bruinenberg et al. [@CR3]). As a consequence more carbon may be diverted towards the NADP^+^-catalyzed formation of acetate that is a direct precursor for PHB synthesis.Table 4**Comparison of selected PHB producing** ***S. cerevisiae*** **strains harbouring the** ***C. necator*** **PHB pathway, consuming different carbon sourcesStrainGenotypeCarbon sourceGrowth conditionsPHB yield/carbon sourcePHB content (mg/g CDW)Reference(mg/g)(Cmmol/Cmol)**SCKK005PHB pathwayGlucoseShake flask\~1.5^a^2.1^a^4.02(Kocharin et al. [@CR16])SCK006PHB pathway, *ADH2*, *ALD6*, *acs* ^L641P^, *ERG10*GlucoseShake flask\~5^a^7^a^15.89(Kocharin et al. [@CR16])SCK032PHB pathway, *xpkA*, *ack*, *acs* ^L641P^GlucoseShake flask\~9^a^12.5^a^27.86(Kocharin et al. [@CR16])SCK034PHB pathway, *gapN*, *ADH2*, *ALD6*, *acs* ^L641P^, *ERG10*GlucoseShake flask\~7^a^9.8^a^27.52(Kocharin et al. [@CR16])SCKK006PHB pathway, *ADH2*, *ALD6*, *acs* ^L641P^, *ERG10*GlucoseAerobic, chemostat bioreactor, dilution rate 0.10 h^−1^2.793.675.59(Kocharin and Nielsen [@CR14])Strain RKSGAL1-10-induced PHB pathwayGalactose/GlucoseAerobic, batch bioreactor13.5^b^18.8^b^75(Carlson and Srienc [@CR4])TMB4443PHB Pathway, *XYL1*, *XYL2*, *XKS*, PPP↑, *gre3*ΔXyloseShake flask1.171.6310.4This studyTMB4443PHB Pathway, *XYL1*, *XYL2*, *XKS*, PPP↑, *gre3*ΔXyloseAerobic, batch bioreactor1.992.794.9This study^a)^Recalculated from graph presented in the respective references, based on total consumption of carbon sources.^b)^Calculated based on total consumption of carbon sources.

The final titer reached a total of 45.0 ± 3.5 mg L^−1^ of PHB for TMB 4443 (PHB+) in shake flask conditions, and increased to 101.7 ± 7.1 mg L^−1^ of PHB in well-aerated bioreactor. By-product accumulation was much lower in the fully aerobic and pH-controlled bioreactor set-up than in the shake-flask experiment, indicating increased respiratory metabolism that directly translated into higher biomass. This may explain the positive impact on PHB production as more cells were available to synthesize PHB while less carbon was dissipated into reduced byproducts. This observation was made despite the fact that low levels of acetate, that is required for PHB production (Figure [4](#Fig4){ref-type="fig"}), were generated. In contrast, unusually high NADP^+^-catalyzed acetate levels were observed in the shake flask experiments. In that case, the limited respiration may trigger higher availability of acetaldehyde precursor; this, combined with the need for additional routes for NADPH generation for biomass synthesis and for xylose utilization via the NAD(P)H-dependent xylose reductase, could explain the dramatic increase in acetate production. It may also explain why xylose consumption stopped before completion as pH decreased over time (data not shown). The accumulation of acetate also indicates that, under these conditions, PHB generation may rather be controlled by reactions downstream of acetate (Figure [4](#Fig4){ref-type="fig"}). This includes the acetyl-CoA synthesis that has been shown to be limited by the availability of ATP and by the efficiency of the acetyl-CoA synthetase (Shiba et al. [@CR27]), or the acetoacetyl-CoA reductase-catalyzed reduction that could be limited by NADPH shortage. Overall, the results indicate that a threshold in oxygenation may be necessary to provide sufficient resources for biomass synthesis while enabling sufficient formation and further conversion of the acetate precursor.Figure 4**A condensed view of the glycolytic pathway steps, as well as the XR and PHB pathway steps that are relevant for the PHB accumulation in the constructed strain.** Abbreviations: EtOH, ethanol; Ac-CoA, acetyl coenzyme A; G3P, glyceraldehyde 3-phosphate; PPP, pentose phosphate pathway The parts marked in red are the introduced xylose assimilation pathway and the overexpressed PPP. The parts marked in blue are the components of the PHB metabolic pathway.

In this report PHB production from xylose was demonstrated in *S. cerevisiae.* Our results also point towards the importance of aeration on the synthesis of the PHB pathway precursor and cofactors. To further enhance the PHB accumulation process aspects such as redox balance and the acetyl-CoA node have to be considered.
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